Legionnaires' disease.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004196:Disease Outbreaks / Q000453:epidemiology*; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007875:Legionella / Q000254:growth & development / Q000648:ultrastructure; D007877:Legionnaires' Disease / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology / Q000635:transmission; D008297:Male; D008875:Middle Aged; D010414:Pennsylvania; D006113:United Kingdom; D014481:United States
D000900:Anti-Bacterial Agents; D004917:Erythromycin